TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression. Wang C, Zhang S, Ma B, Fu Y, et al. Oncogene 2022 Mar 7. pii: 10.1038/s41388-022-02260.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang C, Zhang S, Ma B, Fu Y, et al. TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression. Oncogene 2022 Mar 7. pii: 10.1038/s41388-022-02260.
PMID: 35256783